Prophylactic Fingolimod Administration Prevents the Development of Proliferative Vitreoretinopathy in an Experimental Rat Model.
PURPOSE This study aimed to evaluate the prophylactic potential of fingolimod, an FDA-approved sphingosine-1-phosphate receptor modulator, in preventing proliferative vitreoretinopathy (PVR) in an experimental rat model induced by intravitreal platelet-rich plasma (PRP) injection. METHODS Thirty-two male Wistar albin...